Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00182
Abstract: Here, we propose tailored lipid liquid-crystalline carriers (cubosomes), which incorporate an anticancer drug (doxorubicin) and complexed short-lived α-emitter (bismuth-213), as a strategy to obtain more effective action toward the cancer cells. Cubosomes were formulated with…
read more here.
Keywords:
cubosomal lipid;
dox;
agent;
lipid formulation ... See more keywords